New patent expiration for Xspire Pharma drug ZONTIVITY
Annual Drug Patent Expirations for ZONTIVITY Zontivity is a drug marketed by Xspire Pharma and is included in one NDA. […]
New patent expiration for Xspire Pharma drug ZONTIVITY Read Post »
Annual Drug Patent Expirations for ZONTIVITY Zontivity is a drug marketed by Xspire Pharma and is included in one NDA. […]
New patent expiration for Xspire Pharma drug ZONTIVITY Read Post »
Annual Drug Patent Expirations for INTELENCE Intelence is a drug marketed by Janssen R And D and is included in
New patent expiration for Janssen R drug INTELENCE Read Post »
FYCOMPA (perampanel) Eisai inc Patent: 6,949,571 Expiration: Jun 8, 2021 See More … For more information on how DrugPatentWatch can
Drug Patent Expirations for the Week of June 6, 2021 Read Post »
Annual Drug Patent Expirations for FYCOMPA Fycompa is a drug marketed by Eisai Inc and is included in two NDAs.
New patent expiration for Eisai Inc drug FYCOMPA Read Post »
Annual Drug Patent Expirations for VIBATIV Vibativ is a drug marketed by Cumberland Pharms and is included in one NDA.
New patent expiration for Cumberland Pharms drug VIBATIV Read Post »
Annual Drug Patent Expirations for QUTENZA Qutenza is a drug marketed by Averitas and is included in one NDA. There
Annual Drug Patent Expirations for CARAC Carac is a drug marketed by Valeant Pharms North and is included in one
New patent expiration for Valeant Pharms drug CARAC Read Post »
VIBATIV (telavancin hydrochloride) Cumberland pharms Patent: 6,872,701 Expiration: Jun 5, 2021 See More … For more information on how DrugPatentWatch
Drug Patent Expirations for the Week of May 30, 2021 Read Post »
Annual Drug Patent Expirations for ZOMIG Zomig is a drug marketed by Astrazeneca and IPR and is included in three
New patent expiration for Astrazeneca drug ZOMIG Read Post »
Get fresh news and insights, drug patent expirations & more…